Quality control is central to safety and generally covers cell count and viability, surface marker confirmation, testing for bacteria, fungi and mycoplasma, endotoxin levels and assessment of cell stability across passages. Patients are entitled to request the release-testing summary for the lot intended for them.
Information sources
- EHL BIO — GMP center · retrieved 2 Sept 2026
- EHL BIO — R&D · retrieved 2 Sept 2026